Last reviewed · How we verify
NCT02315469
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
trial testing Comprehensive Geriatric Assessment in Endometrial Serous Adenocarcinoma in 190 participants. Completed in 9 February 2019.
15 March 2016
Quick facts
| Lead sponsor | NRG Oncology |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 190 |
| Start date | 10 February 2015 |
| Primary completion | 15 March 2016 |
| Estimated completion | 9 February 2019 |
| Sites | 393 locations across Canada, United States |
Drugs / interventions tested
- Comprehensive Geriatric Assessment
- Questionnaire Administration
Conditions studied
- Endometrial Serous Adenocarcinoma — all drugs for Endometrial Serous Adenocarcinoma →
- Fallopian Tube Carcinoma — all drugs for Fallopian Tube Carcinoma →
- Malignant Female Reproductive System Neoplasm — all drugs for Malignant Female Reproductive System Neoplasm →
- Ovarian Carcinoma — all drugs for Ovarian Carcinoma →
Sponsor
NRG Oncology — full company profile →
Who can join
70 and older, female only, with Endometrial Serous Adenocarcinoma or Fallopian Tube Carcinoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This research trial studies comprehensive patient questionnaires in predicting complications in older patients with gynecologic cancer undergoing surgery. Comprehensive patient questionnaires completed before surgery may help identify complications, such as the need for assistance in taking medications, decreased mobility, decreased social activity, and falls, and may improve outcomes for older patients with gynecologic cancer.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Improving outcomes for older women with gynaecological malignancies.
Dumas L, Ring A, Butler J, Kalsi T, et al · · 2016 · cited 37× · PMID 27664393 · DOI 10.1016/j.ctrv.2016.08.007
Verify or expand the search:
- PubMed search for NCT02315469
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Comprehensive Geriatric Assessment
Trials testing the same drug.
- NCT07487298 — G8 Screening Tool Validation in Older Adults With Cancer in Portugal · not yet recruiting
- NCT07302737 — Delirium and Heart Failure · not yet recruiting
- NCT06139627 — Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherap · NA · recruiting
- NCT06022965 — Telemedicine for Improvement of Care for Older Adults With Cancer in the Underserved Community, The GAIN-S Trial · NA · recruiting
- NCT06052826 — Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years an · Phase 2 · recruiting
Other recruiting trials for Endometrial Serous Adenocarcinoma
Currently open trials in the same condition.
- NCT05256225 — Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci · Phase 3 · recruiting
- NCT04494113 — Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of · EARLY_PHASE1 · active not recruiting
- NCT03914612 — Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carbopl · Phase 3 · active not recruiting
- NCT05049538 — Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers · recruiting
- NCT03660826 — Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib A · Phase 2 · active not recruiting
Other NRG Oncology trials
Trials by the same sponsor.
- NCT07441681 — Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive · Phase 3 · not yet recruiting
- NCT07452458 — Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, ID · Phase 3 · not yet recruiting
- NCT07166406 — Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO- · Phase 3 · recruiting
- NCT07097142 — Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemothera · Phase 3 · recruiting
- NCT06958328 — Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer · Phase 3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02315469 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NRG Oncology
- Last refreshed: 24 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02315469.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing